This is a Validated Antibody Database (VAD) review about human CXCR4, based on 125 published articles (read how Labome selects the articles), using CXCR4 antibody in all methods. It is aimed to help Labome visitors find the most suited CXCR4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CXCR4 synonym: CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM; WHIMS

others
  • immunohistochemistry - paraffin section; human; 1:128,000; loading ...; fig 1c, 2, 5, 6
 CXCR4 antibody (R&D Systems, 44716) was used in immunohistochemistry - paraffin section on human samples at 1:128,000 (fig 1c, 2, 5, 6). Invest Ophthalmol Vis Sci (2019) ncbi
BioLegend
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 3e, e4k
BioLegend CXCR4 antibody (BioLegend, 306514) was used in flow cytometry on human samples (fig 3e, e4k). Nat Neurosci (2022) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig s4e
BioLegend CXCR4 antibody (BioLegend, 306505) was used in flow cytometry on human samples (fig s4e). Cell Death Dis (2022) ncbi
mouse monoclonal (12G5)
  • flow cytometry; mouse; loading ...; fig 1g, 1i
BioLegend CXCR4 antibody (BioLegend, 306510) was used in flow cytometry on mouse samples (fig 1g, 1i). Int J Mol Sci (2021) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2a, 2b, 2c, 2e
BioLegend CXCR4 antibody (BioLegend, 306510) was used in flow cytometry on human samples (fig 2a, 2b, 2c, 2e). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (12G5)
  • mass cytometry; human; 500 ug/ml; loading ...; fig s11a
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in mass cytometry on human samples at 500 ug/ml (fig s11a). Nature (2020) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry; human; loading ...; fig 2d
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in immunohistochemistry on human samples (fig 2d). Bone Rep (2020) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig s3
BioLegend CXCR4 antibody (BioLegend, 306527) was used in flow cytometry on human samples (fig s3). Stem Cell Res Ther (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CXCR4 antibody (BioLegend, 306506) was used in flow cytometry on human samples (fig s1b). J Exp Med (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 4e
BioLegend CXCR4 antibody (BioLegend, 306506) was used in flow cytometry on human samples (fig 4e). Cancer Res (2018) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig st1
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (fig st1). J Exp Med (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 1c
In order to study the mechanism of internalization of CXCR4 receptor dependent on MIM and small Rab GTPases., BioLegend CXCR4 antibody (biolegend, 306506) was used in flow cytometry on human samples (fig 1c). J Cell Sci (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:100; loading ...; fig s4b
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples at 1:100 (fig s4b). Nat Commun (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (fig 2b). Stem Cells Dev (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BioLegend CXCR4 antibody (BD Pharmingen/BioLegend, I2G5) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (12G5)
BioLegend CXCR4 antibody (BioLegend, 306517) was used . Stem Cell Reports (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 2 ug/ml; fig 5b
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples at 2 ug/ml (fig 5b). Nat Commun (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (fig 2). J Leukoc Biol (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; mouse; fig 4c
BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on mouse samples (fig 4c). J Immunol (2016) ncbi
mouse monoclonal (12G5)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend CXCR4 antibody (BIOLegend, 12G5) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (12G5)
BioLegend CXCR4 antibody (BioLegend, 306510) was used . Sci Rep (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend CXCR4 antibody (Biolegend, 306510) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BioLegend CXCR4 antibody (Biolegend, 306510) was used in flow cytometry on human samples . Cancer Lett (2015) ncbi
mouse monoclonal (12G5)
In order to elucidate the mechanism by which IFN-beta1b suppresses relapsing-remitting multiple sclerosis, BioLegend CXCR4 antibody (Biolegend, 12G5) was used . Clin Exp Immunol (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:200; fig s4
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples at 1:200 (fig s4). Nat Commun (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BioLegend CXCR4 antibody (Biolegend Nos, 306505) was used in flow cytometry on human samples . J Vasc Res (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 5
BioLegend CXCR4 antibody (BioLegend, 306506) was used in flow cytometry on human samples (fig 5). Glycobiology (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 3
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples (fig 3). Clin Cancer Res (2015) ncbi
mouse monoclonal (12G5)
BioLegend CXCR4 antibody (BioLegend, 12G5) was used . Blood Cells Mol Dis (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BioLegend CXCR4 antibody (Biolegend, 12G5) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2f
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, BioLegend CXCR4 antibody (BioLegend, 12G5) was used in flow cytometry on human samples (fig 2f). Blood (2014) ncbi
mouse monoclonal (12G5)
BioLegend CXCR4 antibody (BioLegend, 12G5) was used . J Immunol (2014) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BioLegend CXCR4 antibody (Biolegend, 306505) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
Invitrogen
mouse monoclonal (12G5)
  • western blot; mouse; 2 ug/ml; loading ...; fig 2b
Invitrogen CXCR4 antibody (Invitrogen, 12G5) was used in western blot on mouse samples at 2 ug/ml (fig 2b). Gastric Cancer (2022) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry; mouse; 1:50; fig 5f
Invitrogen CXCR4 antibody (Thermo Fisher Scientific, 35-8800) was used in immunohistochemistry on mouse samples at 1:50 (fig 5f). BMC Cancer (2021) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 1s1a
Invitrogen CXCR4 antibody (Ebioscience, 17-9999-42) was used in flow cytometry on human samples (fig 1s1a). elife (2020) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:50; fig 3a, 3b
Invitrogen CXCR4 antibody (eBioscience/Thermo, 12-9999-42) was used in flow cytometry on human samples at 1:50 (fig 3a, 3b). Stem Cells (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2b
Invitrogen CXCR4 antibody (eBioscience, 12G5) was used in flow cytometry on human samples (fig 2b). Front Immunol (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2d
Invitrogen CXCR4 antibody (eBioscience, 12G5) was used in flow cytometry on human samples (fig 2d). J Exp Med (2018) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2e
In order to discover new regulatory proteins involved in Rap1-dependent T-cell adhesion and migration., Invitrogen CXCR4 antibody (eBioscience, 12G5) was used in flow cytometry on human samples (fig 2e). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1d
In order to assess the male genital compartment in patients with chronic prostatitis/chronic pelvic pain syndrome, Invitrogen CXCR4 antibody (Thermo Fisher Scientific, PA5-19856) was used in western blot on human samples at 1:1000 (fig 1d). Urol Int (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 2
In order to characterize mapping of AHR expression throughout human development by genome editing of the CYP1A1 locus in iPSCs as a platform, Invitrogen CXCR4 antibody (Invitrogen, MHCXCR404) was used in flow cytometry on human samples (fig 2). Stem Cells Int (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; tbl 2
In order to investigate the association between progenitor cells and cognition in a sample of healthy adults, Invitrogen CXCR4 antibody (EBioscience, 12G5) was used in flow cytometry on human samples (tbl 2). Am J Med Sci (2016) ncbi
mouse monoclonal (12G5)
  • immunocytochemistry; mouse; fig 7
  • immunocytochemistry; human; loading ...; fig 7
In order to study cluster formation and migration in response to stromal-derived growth factor by various central nervous system cell types, Invitrogen CXCR4 antibody (Life Technologies, 35-8800) was used in immunocytochemistry on mouse samples (fig 7) and in immunocytochemistry on human samples (fig 7). Cell Adh Migr (2017) ncbi
mouse monoclonal (12G5)
  • immunocytochemistry; human; 5 ug/ml; loading ...; fig 2b
In order to examine the role of epidermal growth factor in medulloblastoma chemotactic migration, Invitrogen CXCR4 antibody (Life Technologies, 35-8800) was used in immunocytochemistry on human samples at 5 ug/ml (fig 2b). Cell Mol Bioeng (2015) ncbi
mouse monoclonal (12G5)
  • immunocytochemistry; human
In order to examine the effects of pantethine on membrane lipid rafts, Invitrogen CXCR4 antibody (Invitrogen, 12G5) was used in immunocytochemistry on human samples . J Cell Physiol (2015) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry; human; tbl 4
In order to describe protocols to directed differentiation of protein folding disease-specific iPSCs into hepatocytes and neural-lineage cells, Invitrogen CXCR4 antibody (Invitrogen, MHCXCR404) was used in immunohistochemistry on human samples (tbl 4). Methods Mol Biol (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; tbl 2
In order to test if flow cytometry can be used to find mantle cell lymphoma, Invitrogen CXCR4 antibody (eBioscience, 12G5) was used in flow cytometry on human samples (tbl 2). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry - paraffin section; human; 1:50
In order to investigate the effect of neoadjuvant chemoradiotherapy on pancreatic adenocarcinoma cancer stem cell markers, Invitrogen CXCR4 antibody (Zymed, 35-8800) was used in immunohistochemistry - paraffin section on human samples at 1:50. BMC Cancer (2014) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig s1b
Invitrogen CXCR4 antibody (eBioscience, 25-9999-42) was used in flow cytometry on human samples (fig s1b). Oncotarget (2014) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry - paraffin section; human; 1:1200
In order to discuss the role of chemokines in brain metastasis observed in patients with renal cell cancer, Invitrogen CXCR4 antibody (Zymed, 12G5) was used in immunohistochemistry - paraffin section on human samples at 1:1200. Br J Cancer (2014) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry; human; 1:25; tbl 3
In order to correlate expression of proteins in the primary tumor with the risk of brain metastases in patients with metastatic breast cancer, Invitrogen CXCR4 antibody (Invitrogen, 358800) was used in immunohistochemistry on human samples at 1:25 (tbl 3). Breast (2013) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 1
In order to investigate how mesenchymal stem cells improve hematopoietic stem cell transplantability, Invitrogen CXCR4 antibody (Caltag, 12G5) was used in flow cytometry on human samples (fig 1). Int J Hematol (2011) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry - paraffin section; human; fig 4
In order to examine karyopherin alpha 2 expression in prostate cancer samples, Invitrogen CXCR4 antibody (Invitrogen, MHCXCR404) was used in immunohistochemistry - paraffin section on human samples (fig 4). Clin Cancer Res (2011) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
In order to review protocols for functionalization and bioconjugation of single-walled carbon nanotubes, Invitrogen CXCR4 antibody (Caltag, MHCXCR404) was used in flow cytometry on human samples . Nat Protoc (2009) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
In order to measure the expression of CXCR4, actinin-4, and CD133 in primary and recurrent pancreatic ductal adenocarcinoma, Invitrogen CXCR4 antibody (Zymed, 12G5) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Clin Exp Metastasis (2009) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 1a
Invitrogen CXCR4 antibody (eBioscience, 12G5) was used in flow cytometry on human samples (fig 1a). Blood (2008) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...
In order to assess the effects of using GM-CSF DNA with the DNA prime for a simian-human immunodeficiency virus-89.6 vaccine, Invitrogen CXCR4 antibody (eBiosciences, 12G5) was used in flow cytometry on human samples . Virology (2007) ncbi
mouse monoclonal (12G5)
  • immunohistochemistry - paraffin section; human; 1:50; fig 5B
In order to examine the gene expression profiles of intraductal papillary mucinous neoplasms, Invitrogen CXCR4 antibody (Zymed, 12G5) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 5B). Am J Pathol (2004) ncbi
Abcam
domestic rabbit monoclonal (UMB2)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4h
  • western blot; mouse; loading ...; fig s4f
Abcam CXCR4 antibody (Abcam, ab124824) was used in immunohistochemistry - paraffin section on mouse samples (fig s4h) and in western blot on mouse samples (fig s4f). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (EPUMBR3)
  • immunohistochemistry; mouse; 1:1000; fig 6i
Abcam CXCR4 antibody (Abcam, ab181020) was used in immunohistochemistry on mouse samples at 1:1000 (fig 6i). Cell Rep (2021) ncbi
domestic rabbit monoclonal (UMB2)
  • western blot; human; 1:2000; loading ...; fig 2e
Abcam CXCR4 antibody (Abcam, ab124824) was used in western blot on human samples at 1:2000 (fig 2e). Stem Cell Res Ther (2021) ncbi
domestic rabbit monoclonal (UMB2)
  • immunohistochemistry; human; loading ...; fig 1c
Abcam CXCR4 antibody (Abcam, ab124824) was used in immunohistochemistry on human samples (fig 1c). EJNMMI Res (2021) ncbi
domestic rabbit monoclonal (UMB2)
  • western blot; mouse; 1:1000; loading ...; fig s9b
Abcam CXCR4 antibody (Abcam, ab124824) was used in western blot on mouse samples at 1:1000 (fig s9b). Nat Commun (2021) ncbi
domestic rabbit monoclonal (EPUMBR3)
  • western blot; human; 1:1000; loading ...; fig 4c
Abcam CXCR4 antibody (Abcam, ab181020) was used in western blot on human samples at 1:1000 (fig 4c). Mol Med Rep (2019) ncbi
domestic rabbit monoclonal (EPUMBR3)
  • immunocytochemistry; human; loading ...; fig 4h
  • western blot; human; 1:1000; loading ...; fig 5m
Abcam CXCR4 antibody (Abcam, ab181020) was used in immunocytochemistry on human samples (fig 4h) and in western blot on human samples at 1:1000 (fig 5m). Cancer Res (2018) ncbi
domestic rabbit monoclonal (UMB2)
  • western blot; mouse; fig 3a
  • western blot; human; fig 1d
Abcam CXCR4 antibody (Abcam, ab-124824) was used in western blot on mouse samples (fig 3a) and in western blot on human samples (fig 1d). Oncotarget (2016) ncbi
domestic rabbit monoclonal (UMB2)
  • western blot; human; loading ...; fig 1a
Abcam CXCR4 antibody (Abcam, ab124824) was used in western blot on human samples (fig 1a). Int J Mol Sci (2016) ncbi
domestic rabbit monoclonal (UMB2)
  • western blot; human; loading ...; fig 4b
In order to find that CXCR4 is involved in the differentiation of human embryonic stem cells to neural stem cells, Abcam CXCR4 antibody (Abcam, ab124824) was used in western blot on human samples (fig 4b). Neuroscience (2016) ncbi
domestic rabbit monoclonal (UMB2)
  • immunohistochemistry - paraffin section; human; 1:4000; fig 2a
In order to test if CXCR4 impacts tumor growth, Abcam CXCR4 antibody (abcam, ab124824) was used in immunohistochemistry - paraffin section on human samples at 1:4000 (fig 2a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (UMB2)
  • western blot; mouse; 1:100; fig 1
In order to utilize a mouse hindlimb ischemia model to show improvement of tissue regeneration and stem cell engraftment through polymer-DNA nanoparticle-induced CXCR4 overexpression, Abcam CXCR4 antibody (Abcam, ab124824) was used in western blot on mouse samples at 1:100 (fig 1). Theranostics (2016) ncbi
domestic rabbit monoclonal (UMB2)
  • immunohistochemistry - frozen section; human; fig s2c, g
Abcam CXCR4 antibody (Abcam, ab124824) was used in immunohistochemistry - frozen section on human samples (fig s2c, g). Arthritis Res Ther (2016) ncbi
  • immunohistochemistry; human; 1:20; tbl 2
In order to evaluate the reliance on EBV or NF-kappaB signaling instead of B-cell receptor signaling in regards to complete phenotypic characterization of PTLD, Abcam CXCR4 antibody (Abcam, ab74012) was used in immunohistochemistry on human samples at 1:20 (tbl 2). Hematol Oncol (2017) ncbi
  • western blot; mouse; 1:500; fig 4
Abcam CXCR4 antibody (Abcam, 74012) was used in western blot on mouse samples at 1:500 (fig 4). Leukemia (2016) ncbi
  • western blot; human; 1:1000
Abcam CXCR4 antibody (Abcam, ab74012) was used in western blot on human samples at 1:1000. PLoS ONE (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (4G10)
  • western blot; human; 1:200; loading ...; fig 5a
Santa Cruz Biotechnology CXCR4 antibody (Santa Cruz, SC-53534) was used in western blot on human samples at 1:200 (fig 5a). Nat Commun (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:100; loading ...; fig s1b
Santa Cruz Biotechnology CXCR4 antibody (Santa Cruz, sc-12764) was used in flow cytometry on human samples at 1:100 (fig s1b). Sci Adv (2019) ncbi
mouse monoclonal (4G10)
  • western blot; human; loading ...; fig s2g
Santa Cruz Biotechnology CXCR4 antibody (SCBT, sc-53534) was used in western blot on human samples (fig s2g). Mol Cell (2019) ncbi
mouse monoclonal (4G10)
  • western blot; mouse; 1:1000; loading ...; fig 6c
Santa Cruz Biotechnology CXCR4 antibody (Santa, sc-53534) was used in western blot on mouse samples at 1:1000 (fig 6c). Nat Commun (2018) ncbi
mouse monoclonal (4G10)
  • immunohistochemistry - frozen section; rat; loading ...; fig 6b
  • immunocytochemistry; rat; loading ...; fig 3f
  • western blot; rat; loading ...; fig 3e
Santa Cruz Biotechnology CXCR4 antibody (SantaCruz, sc-53534) was used in immunohistochemistry - frozen section on rat samples (fig 6b), in immunocytochemistry on rat samples (fig 3f) and in western blot on rat samples (fig 3e). Oncotarget (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 4a
Santa Cruz Biotechnology CXCR4 antibody (SantaCruz, 12G5) was used in flow cytometry on human samples (fig 4a). Viruses (2017) ncbi
mouse monoclonal (4G10)
  • western blot; mouse; loading ...; fig 2a
In order to study the mechanism of internalization of CXCR4 receptor dependent on MIM and small Rab GTPases., Santa Cruz Biotechnology CXCR4 antibody (Santa Cruz, sc-53534) was used in western blot on mouse samples (fig 2a). J Cell Sci (2017) ncbi
mouse monoclonal (4G10)
  • immunohistochemistry - paraffin section; human; fig 1I
  • western blot; human; fig 1C
Santa Cruz Biotechnology CXCR4 antibody (Santa Cruz, sc-53534) was used in immunohistochemistry - paraffin section on human samples (fig 1I) and in western blot on human samples (fig 1C). J Hematol Oncol (2017) ncbi
mouse monoclonal (4G10)
  • immunocytochemistry; human; fig 5
In order to determine a mechanism for regulation of tumor progression due to simultaneous activation of induced heterodimerization between cannabinoid receptor 2 (CB2) and CXCR4 chemokine receptor, Santa Cruz Biotechnology CXCR4 antibody (Santa Cruz, sc-53534) was used in immunocytochemistry on human samples (fig 5). J Biol Chem (2016) ncbi
mouse monoclonal (4G10)
  • immunohistochemistry - paraffin section; human; fig 1
Santa Cruz Biotechnology CXCR4 antibody (Santa Cruz, sc-53534) was used in immunohistochemistry - paraffin section on human samples (fig 1). Oncotarget (2015) ncbi
R&D Systems
mouse monoclonal (44716)
  • immunocytochemistry; mouse; loading ...; fig 4e, 4f
  • western blot; mouse; 1:100; loading ...; fig 4e, 4f
R&D Systems CXCR4 antibody (R&D System, MAB172) was used in immunocytochemistry on mouse samples (fig 4e, 4f) and in western blot on mouse samples at 1:100 (fig 4e, 4f). Adv Sci (Weinh) (2021) ncbi
Abnova
mouse monoclonal (2G9)
  • proximity ligation assay; human; 1:400; fig 1
  • flow cytometry; human; fig 1
Abnova CXCR4 antibody (Abnova, M04) was used in proximity ligation assay on human samples at 1:400 (fig 1) and in flow cytometry on human samples (fig 1). Int J Mol Sci (2016) ncbi
National Institutes of Health AIDS Research and Reference Reagent Program
mouse monoclonal (44717)
  • flow cytometry; human; loading ...; fig 3e
National Institutes of Health AIDS Research and Reference Reagent Program CXCR4 antibody (NIH AIDS Reagent, 4083) was used in flow cytometry on human samples (fig 3e). J Virol (2019) ncbi
BD Biosciences
mouse monoclonal (12G5)
  • flow cytometry; human; 1:10; fig 2b, s3a
BD Biosciences CXCR4 antibody (BD Biosciences, 555974) was used in flow cytometry on human samples at 1:10 (fig 2b, s3a). Diabetes (2021) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CXCR4 antibody (BD Biosciences, 12G5) was used in flow cytometry on human samples (fig 1b). Sci Adv (2020) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CXCR4 antibody (BD Pharmingen, 555974) was used in flow cytometry on human samples (fig 5a). Stem Cell Reports (2019) ncbi
mouse monoclonal (12G5)
  • immunocytochemistry; human; loading ...; fig s1a
BD Biosciences CXCR4 antibody (BD Biosciences, 555974) was used in immunocytochemistry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences CXCR4 antibody (BD Biosciences, 560936) was used in flow cytometry on human samples (fig 2d). Mol Cell (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CXCR4 antibody (BD Biosciences, 12G5) was used in flow cytometry on human samples (fig s3). Eur J Immunol (2019) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CXCR4 antibody (BD Pharmigen, 12G5) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2018) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 5c
BD Biosciences CXCR4 antibody (BD Pharmingen, 560937) was used in flow cytometry on human samples (fig 5c). Stem Cells Transl Med (2018) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:200; fig 3a
BD Biosciences CXCR4 antibody (BD, 555976) was used in flow cytometry on human samples at 1:200 (fig 3a). Sci Rep (2018) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences CXCR4 antibody (BD, 555976) was used in flow cytometry on human samples (fig 5b). J Exp Med (2018) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CXCR4 antibody (Becton Dickinson, 12G5) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; tbl 1
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences CXCR4 antibody (Becton Dickinson, 12G5) was used in flow cytometry on human samples (tbl 1). J Leukoc Biol (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CXCR4 antibody (BD Bioscience, 555974) was used in flow cytometry on human samples (fig 3a). Leukemia (2017) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CXCR4 antibody (BD Pharmingen, 12G5) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:20; loading ...; tbl 1
In order to describe a method to produce human embryonic stem cell-derived Beta-like cells, BD Biosciences CXCR4 antibody (BD, 561733) was used in flow cytometry on human samples at 1:20 (tbl 1). PLoS ONE (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 1a
In order to demonstrate a novel mechanism by which HIV-1 invades ocular tissues and promotes translocation or invasion by additional pathogens, BD Biosciences CXCR4 antibody (BD Pharmingen, 12G5) was used in flow cytometry on human samples (fig 1a). J Biol Chem (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 10d
BD Biosciences CXCR4 antibody (BD Pharmingen, 555974) was used in flow cytometry on human samples (fig 10d). Sci Rep (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
In order to assess the contribution of cytomorphology and flow cytometry to histopathological studies of brain biopsies, BD Biosciences CXCR4 antibody (BD Biosciences, 12G5) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CXCR4 antibody (BD, 555974) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 1d
In order to develop a robust in vitro model to study chronic lymphocytic leukemia B cell receptor ligation, BD Biosciences CXCR4 antibody (BD Biosciences, 12G5) was used in flow cytometry on human samples (fig 1d). Br J Cancer (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:10; fig 1
BD Biosciences CXCR4 antibody (BD, 555976) was used in flow cytometry on human samples at 1:10 (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BD Biosciences CXCR4 antibody (BD Pharmingen, BD555976) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:50; fig 1
BD Biosciences CXCR4 antibody (BD, 555976) was used in flow cytometry on human samples at 1:50 (fig 1). Development (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 8
BD Biosciences CXCR4 antibody (BD Biosciences, 560670) was used in flow cytometry on human samples (fig 8). Retrovirology (2015) ncbi
mouse monoclonal (12G5)
  • immunocytochemistry; human; tbl 2
BD Biosciences CXCR4 antibody (BD Bioscience, 561733) was used in immunocytochemistry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; loading ...; fig 5f
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences CXCR4 antibody (BD Pharmingen, 12G5) was used in flow cytometry on human samples (fig 5f). Retrovirology (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 1
BD Biosciences CXCR4 antibody (Becton Dickinson, 555974) was used in flow cytometry on human samples (fig 1). Theranostics (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
In order to study the effect of non-POU domain-containing octamer-binding protein (NonO) on the HIV-1 life cycle in CD4(+) T cells, BD Biosciences CXCR4 antibody (BD Pharmingen, 555974) was used in flow cytometry on human samples . AIDS Res Hum Retroviruses (2015) ncbi
mouse monoclonal (12G5)
  • western blot; human; 1:200
In order to describe a method to generate cystic fibrosis transmembrane conductance regulator protein-expressing airway epithelial cells from human pluripotent stem cells, BD Biosciences CXCR4 antibody (BD, 560669) was used in western blot on human samples at 1:200. Nat Protoc (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 2
BD Biosciences CXCR4 antibody (BD Biosciences, 12G5) was used in flow cytometry on human samples (fig 2). Blood Cells Mol Dis (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; 1:50
BD Biosciences CXCR4 antibody (BD, 555974) was used in flow cytometry on human samples at 1:50. Stem Cells (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; rhesus macaque
BD Biosciences CXCR4 antibody (BD Biosciences, 12G5) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BD Biosciences CXCR4 antibody (BD, 12G5) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BD Biosciences CXCR4 antibody (BD Bioscience, 12G5) was used in flow cytometry on human samples . Immunology (2015) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BD Biosciences CXCR4 antibody (BD Biosciences, 557145) was used in flow cytometry on human samples . Angiogenesis (2014) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 5
BD Biosciences CXCR4 antibody (Becton-Dickinson Pharmingen, 12G5) was used in flow cytometry on human samples (fig 5). Nanomedicine (2014) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human
BD Biosciences CXCR4 antibody (BD Biosciences, 555976) was used in flow cytometry on human samples . J Biol Chem (2013) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 1
BD Biosciences CXCR4 antibody (BD Biosciences, 555974) was used in flow cytometry on human samples (fig 1). PLoS ONE (2012) ncbi
mouse monoclonal (12G5)
  • flow cytometry; human; fig 1
BD Biosciences CXCR4 antibody (BD Pharmingen, 555974) was used in flow cytometry on human samples (fig 1). BMC Immunol (2009) ncbi
Articles Reviewed
  1. Dr xe4 ger N, Sattler S, Huang C, Teter O, Leng K, Hashemi S, et al. A CRISPRi/a platform in human iPSC-derived microglia uncovers regulators of disease states. Nat Neurosci. 2022;25:1149-1162 pubmed publisher
  2. Wu T, Wang W, Shi G, Hao M, Wang Y, Yao M, et al. Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression. Cell Death Dis. 2022;13:624 pubmed publisher
  3. Nakamura Y, Kinoshita J, Yamaguchi T, Aoki T, Saito H, Hamabe Horiike T, et al. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast. Gastric Cancer. 2022;25:515-526 pubmed publisher
  4. Ngamsri K, Putri R, Jans C, Schindler K, Fuhr A, Zhang Y, et al. CXCR4 and CXCR7 Inhibition Ameliorates the Formation of Platelet-Neutrophil Complexes and Neutrophil Extracellular Traps through Adora2b Signaling. Int J Mol Sci. 2021;22: pubmed publisher
  5. Ridge L, Kewbank D, Schütz D, Stumm R, Scambler P, Ivins S. Dual role for CXCL12 signaling in semilunar valve development. Cell Rep. 2021;36:109610 pubmed publisher
  6. Shen J, Sun Y, Liu X, Zhu Y, Bao B, Gao T, et al. EGFL6 regulates angiogenesis and osteogenesis in distraction osteogenesis via Wnt/β-catenin signaling. Stem Cell Res Ther. 2021;12:415 pubmed publisher
  7. Meester E, De Blois E, Krenning B, van der Steen A, Norenberg J, van Gaalen K, et al. Autoradiographical assessment of inflammation-targeting radioligands for atherosclerosis imaging: potential for plaque phenotype identification. EJNMMI Res. 2021;11:27 pubmed publisher
  8. Xie M, Cao X, Zeng W, Lai R, Guo L, Wang J, et al. ATF4 selectively regulates heat nociception and contributes to kinesin-mediated TRPM3 trafficking. Nat Commun. 2021;12:1401 pubmed publisher
  9. Choi Y, Kim Y, Oh S, Suh K, Kim Y, Lee G, et al. Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer. Adv Sci (Weinh). 2021;8:2002497 pubmed publisher
  10. Matsuzawa F, Kamachi H, Mizukami T, Einama T, Kawamata F, Fujii Y, et al. Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells. BMC Cancer. 2021;21:200 pubmed publisher
  11. Montaser H, Patel K, Balboa D, Ibrahim H, Lithovius V, Näätänen A, et al. Loss of MANF Causes Childhood-Onset Syndromic Diabetes Due to Increased Endoplasmic Reticulum Stress. Diabetes. 2021;70:1006-1018 pubmed publisher
  12. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  13. Barruet E, Garcia S, Striedinger K, Wu J, Lee S, Byrnes L, et al. Functionally heterogeneous human satellite cells identified by single cell RNA sequencing. elife. 2020;9: pubmed publisher
  14. Tan S, Yang H, Xue S, Qiao J, Salarian M, Hekmatyar K, et al. Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases. Sci Adv. 2020;6:eaav7504 pubmed publisher
  15. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  16. Zhang Z, Le K, La Placa D, Armstrong B, Miller M, Shively J. CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils. Bone Rep. 2020;12:100237 pubmed publisher
  17. Bredenkamp N, Yang J, Clarke J, Stirparo G, von Meyenn F, Dietmann S, et al. Wnt Inhibition Facilitates RNA-Mediated Reprogramming of Human Somatic Cells to Naive Pluripotency. Stem Cell Reports. 2019;13:1083-1098 pubmed publisher
  18. Yang L, Hong Q, Xu S, Kuang X, Di G, Liu G, et al. Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway. Mol Med Rep. 2019;20:4045-4258 pubmed publisher
  19. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  20. van Ipenburg J, de Waard N, Naus N, Jager M, Paridaens D, Verdijk R. Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions. Invest Ophthalmol Vis Sci. 2019;60:2950-2957 pubmed publisher
  21. Yang S, Wei J, Cui Y, Park G, Shah P, Deng Y, et al. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019;10:2782 pubmed publisher
  22. Okumura T, Horie Y, Lai C, Lin H, Shoda H, Natsumoto B, et al. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector. Stem Cell Res Ther. 2019;10:185 pubmed publisher
  23. Ling C, Nishimoto K, Rolfs Z, Smith L, Frey B, Welham N. Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential. Sci Adv. 2019;5:eaav7384 pubmed publisher
  24. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  25. Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed publisher
  26. Lee S, Mayr C. Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. Mol Cell. 2019;: pubmed publisher
  27. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  28. Chen H, Poran A, Unni A, Huang S, Elemento O, Snoeck H, et al. Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J Exp Med. 2019;216:674-687 pubmed publisher
  29. Yu J, Liang C, Liu S. CD4-Dependent Modulation of HIV-1 Entry by LY6E. J Virol. 2019;93: pubmed publisher
  30. Kim H, Mun Y, Lee K, Park Y, Park J, Park J, et al. T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun. 2018;9:3630 pubmed publisher
  31. Armas González E, Domínguez Luis M, Díaz Martín A, Arce Franco M, Castro Hernandez J, Danelon G, et al. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis. Arthritis Res Ther. 2018;20:114 pubmed publisher
  32. Liao Y, Ivanova L, Sivalenka R, Plumer T, Zhu H, Zhang X, et al. Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model. Stem Cells Transl Med. 2018;7:530-542 pubmed publisher
  33. Seki A, Rutz S. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. J Exp Med. 2018;215:985-997 pubmed publisher
  34. Jung Y, Cackowski F, Yumoto K, Decker A, Wang J, Kim J, et al. CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. Cancer Res. 2018;78:2026-2039 pubmed publisher
  35. Paik E, O Neil A, Ng S, Sun C, Rubin L. Using intracellular markers to identify a novel set of surface markers for live cell purification from a heterogeneous hIPSC culture. Sci Rep. 2018;8:804 pubmed publisher
  36. Tissino E, Benedetti D, Herman S, ten Hacken E, Ahn I, Chaffee K, et al. Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia. J Exp Med. 2018;215:681-697 pubmed publisher
  37. Qin D, Yan Y, Hu B, Zhang W, Li H, Li X, et al. Wisp2 disruption represses Cxcr4 expression and inhibits BMSCs homing to injured liver. Oncotarget. 2017;8:98823-98836 pubmed publisher
  38. Zotova A, Lopatukhina E, Filatov A, Khaitov M, Mazurov D. Gene Editing in Human Lymphoid Cells: Role for Donor DNA, Type of Genomic Nuclease and Cell Selection Method. Viruses. 2017;9: pubmed publisher
  39. Sasaki F, Koga T, Saeki K, Okuno T, Kazuno S, Fujimura T, et al. Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B4 receptor 1. PLoS ONE. 2017;12:e0185133 pubmed publisher
  40. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  41. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  42. Li L, Baxter S, Gu N, Ji M, Zhan X. Missing-in-metastasis protein downregulates CXCR4 by promoting ubiquitylation and interaction with small Rab GTPases. J Cell Sci. 2017;130:1475-1485 pubmed publisher
  43. Strazza M, Azoulay Alfaguter I, Peled M, Smrcka A, Skolnik E, Srivastava S, et al. PLCε1 regulates SDF-1α-induced lymphocyte adhesion and migration to sites of inflammation. Proc Natl Acad Sci U S A. 2017;114:2693-2698 pubmed publisher
  44. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  45. Chorzalska A, Kim J, Roder K, Tepper A, Ahsan N, Rao R, et al. Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia. Stem Cells Dev. 2017;26:656-677 pubmed publisher
  46. Herndon T, Chen S, Saba N, Valdez J, Emson C, Gatmaitan M, et al. Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood. Leukemia. 2017;31:1340-1347 pubmed publisher
  47. Gravina G, Mancini A, Marampon F, Colapietro A, Delle Monache S, Sferra R, et al. The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma. J Hematol Oncol. 2017;10:5 pubmed publisher
  48. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  49. Yadav V, Zamler D, Baker G, Kadiyala P, Erdreich Epstein A, deCarvalho A, et al. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study. Oncotarget. 2016;7:83701-83719 pubmed publisher
  50. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  51. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  52. Schagdarsurengin U, Teuchert L, Hagenkötter C, Nesheim N, Dansranjavin T, Schuppe H, et al. Chronic Prostatitis Affects Male Reproductive Health and Is Associated with Systemic and Local Epigenetic Inactivation of C-X-C Motif Chemokine 12 Receptor C-X-C Chemokine Receptor Type 4. Urol Int. 2017;98:89-101 pubmed publisher
  53. Massumi M, Pourasgari F, Nalla A, Batchuluun B, Nagy K, Neely E, et al. An Abbreviated Protocol for In Vitro Generation of Functional Human Embryonic Stem Cell-Derived Beta-Like Cells. PLoS ONE. 2016;11:e0164457 pubmed publisher
  54. Lu W, Shi J, Zhang J, Lv Z, Guo F, Huang H, et al. CXCL12/CXCR4 Axis Regulates Aggrecanase Activation and Cartilage Degradation in a Post-Traumatic Osteoarthritis Rat Model. Int J Mol Sci. 2016;17: pubmed
  55. Zhang L, Hua Q, Tang K, Shi C, Xie X, Zhang R. CXCR4 activation promotes differentiation of human embryonic stem cells to neural stem cells. Neuroscience. 2016;337:88-97 pubmed publisher
  56. Qian Y, Li C, Jiang A, Ge S, Gu P, Fan X, et al. HIV-1 gp120 Glycoprotein Interacting with Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Down-Regulates Tight Junction Proteins to Disrupt the Blood Retinal Barrier and Increase Its Permeability. J Biol Chem. 2016;291:22977-22987 pubmed
  57. Krook M, Hawkins A, Patel R, Lucas D, Van Noord R, Chugh R, et al. A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcoma. Oncotarget. 2016;7:61775-61788 pubmed publisher
  58. Godinho Santos A, Hance A, Gonçalves J, Mammano F. CIB1 and CIB2 are HIV-1 helper factors involved in viral entry. Sci Rep. 2016;6:30927 pubmed publisher
  59. Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drenou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94:182-188 pubmed publisher
  60. Evans A, Tripathi A, Laporte H, Brueggemann L, Singh A, Albee L, et al. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. Int J Mol Sci. 2016;17: pubmed publisher
  61. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  62. Deveza L, Choi J, Lee J, HUANG N, Cooke J, Yang F. Polymer-DNA Nanoparticle-Induced CXCR4 Overexpression Improves Stem Cell Engraftment and Tissue Regeneration in a Mouse Hindlimb Ischemia Model. Theranostics. 2016;6:1176-89 pubmed publisher
  63. Shi H, Cao N, Pu Y, Xie L, Zheng L, Yu C. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome. Arthritis Res Ther. 2016;18:109 pubmed publisher
  64. Smith B, Stanford E, Sherr D, Murphy G. Genome Editing of the CYP1A1 Locus in iPSCs as a Platform to Map AHR Expression throughout Human Development. Stem Cells Int. 2016;2016:2574152 pubmed publisher
  65. Saxena S, Ronn R, Guibentif C, Moraghebi R, Woods N. Cyclic AMP Signaling through Epac Axis Modulates Human Hemogenic Endothelium and Enhances Hematopoietic Cell Generation. Stem Cell Reports. 2016;6:692-703 pubmed publisher
  66. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  67. Kamiyama D, Sekine S, Barsi Rhyne B, Hu J, Chen B, Gilbert L, et al. Versatile protein tagging in cells with split fluorescent protein. Nat Commun. 2016;7:11046 pubmed publisher
  68. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  69. Jost T, Borga C, Radaelli E, Romagnani A, Perruzza L, Omodho L, et al. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia. J Leukoc Biol. 2016;99:1077-87 pubmed publisher
  70. Rombout A, Lust S, Offner F, Naessens E, Verhasselt B, Philippé J. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation. Br J Cancer. 2016;114:704-12 pubmed publisher
  71. Sancho Martinez I, Nivet E, Xia Y, Hishida T, Aguirre A, Ocampo A, et al. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells. Nat Commun. 2016;7:10743 pubmed publisher
  72. Hajjar I, Goldstein F, Waller E, Moss L, Quyyumi A. Circulating Progenitor Cells is Linked to Cognitive Decline in Healthy Adults. Am J Med Sci. 2016;351:147-52 pubmed publisher
  73. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  74. Levit Zerdoun E, Becker M, Pohlmeyer R, Wilhelm I, Maity P, Rajewsky K, et al. Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function. J Immunol. 2016;196:2348-60 pubmed publisher
  75. Coke C, Scarlett K, Chetram M, Jones K, Sandifer B, Davis A, et al. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression. J Biol Chem. 2016;291:9991-10005 pubmed publisher
  76. Menter T, Dickenmann M, Juskevicius D, Steiger J, Dirnhofer S, Tzankov A. Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling. Hematol Oncol. 2017;35:187-197 pubmed publisher
  77. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  78. McCutcheon S, Unachukwu U, Thakur A, MAJESKA R, Redenti S, Vazquez M. In vitro formation of neuroclusters in microfluidic devices and cell migration as a function of stromal-derived growth factor 1 gradients. Cell Adh Migr. 2017;11:1-12 pubmed publisher
  79. Ogaki S, Morooka M, Otera K, Kume S. A cost-effective system for differentiation of intestinal epithelium from human induced pluripotent stem cells. Sci Rep. 2015;5:17297 pubmed publisher
  80. Rico Varela J, Singh T, McCutcheon S, Vazquez M. EGF as a New Therapeutic Target for Medulloblastoma Metastasis. Cell Mol Bioeng. 2015;8:553-565 pubmed
  81. Chen S, Chang B, Chang S, Tong T, Ham S, Sherry B, et al. BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia. Leukemia. 2016;30:833-43 pubmed publisher
  82. Holtzinger A, Streeter P, Sarangi F, Hillborn S, Niapour M, Ogawa S, et al. New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells. Development. 2015;142:4253-65 pubmed publisher
  83. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed publisher
  84. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  85. Fernandez L, Valentin J, Zalacain M, Leung W, Patino Garcia A, Perez Martinez A. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner. Cancer Lett. 2015;368:54-63 pubmed publisher
  86. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  87. Wostradowski T, Gudi V, Pul R, Gingele S, Lindquist J, Stangel M, et al. Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients. Clin Exp Immunol. 2015;182:162-72 pubmed publisher
  88. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed publisher
  89. Anderson E, Mooney D. The Combination of Vascular Endothelial Growth Factor and Stromal Cell-Derived Factor Induces Superior Angiogenic Sprouting by Outgrowth Endothelial Cells. J Vasc Res. 2015;52:62-9 pubmed publisher
  90. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  91. Schneider T, Ehrig K, Liewert I, Alban S. Interference with the CXCL12/CXCR4 axis as potential antitumor strategy: superiority of a sulfated galactofucan from the brown alga Saccharina latissima and fucoidan over heparins. Glycobiology. 2015;25:812-24 pubmed publisher
  92. Wester H, Keller U, Schottelius M, Beer A, Philipp Abbrederis K, Hoffmann F, et al. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics. 2015;5:618-30 pubmed publisher
  93. Panneerselvam J, Jin J, Shanker M, Lauderdale J, BATES J, Wang Q, et al. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis. PLoS ONE. 2015;10:e0122439 pubmed publisher
  94. St Gelais C, Roger J, Wu L. Non-POU Domain-Containing Octamer-Binding Protein Negatively Regulates HIV-1 Infection in CD4(+) T Cells. AIDS Res Hum Retroviruses. 2015;31:806-16 pubmed publisher
  95. van Gijsel Bonnello M, Acar N, Molino Y, Bretillon L, Khrestchatisky M, De Reggi M, et al. Pantethine Alters Lipid Composition and Cholesterol Content of Membrane Rafts, With Down-Regulation of CXCL12-Induced T Cell Migration. J Cell Physiol. 2015;230:2415-25 pubmed publisher
  96. Zsiros E, Duttagupta P, Dangaj D, Li H, Frank R, Garrabrant T, et al. The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28-Costimulated T Cells Prepared for Adoptive Therapy. Clin Cancer Res. 2015;21:2840-50 pubmed publisher
  97. Zhu M, Guo J, Li W, Lu Y, Fu S, Xie X, et al. Hepatitis B virus X protein induces expression of alpha-fetoprotein and activates PI3K/mTOR signaling pathway in liver cells. Oncotarget. 2015;6:12196-208 pubmed
  98. Wong A, Chin S, Xia S, Garner J, Bear C, Rossant J. Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells. Nat Protoc. 2015;10:363-81 pubmed publisher
  99. Leung A, Murphy G. Multisystemic Disease Modeling of Liver-Derived Protein Folding Disorders Using Induced Pluripotent Stem Cells (iPSCs). Methods Mol Biol. 2016;1353:261-70 pubmed publisher
  100. Bettman N, Avivi I, Rosenbaum H, Bisharat L, Katz T. Impaired migration capacity in monocytes derived from patients with Gaucher disease. Blood Cells Mol Dis. 2015;55:180-6 pubmed publisher
  101. Lee S, Lee K, Lee J, Kang S, Kim H, Asahara T, et al. Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling. Stem Cells. 2015;33:1490-500 pubmed publisher
  102. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  103. Mandl M, Schmitz S, Weber C, Hristov M. Characterization of the CD14++CD16+ monocyte population in human bone marrow. PLoS ONE. 2014;9:e112140 pubmed publisher
  104. Neumann B, Klippert A, Raue K, Sopper S, Stahl Hennig C. Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry. J Leukoc Biol. 2015;97:19-30 pubmed publisher
  105. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  106. Mizukami T, Kamachi H, Mitsuhashi T, Tsuruga Y, Hatanaka Y, Kamiyama T, et al. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy. BMC Cancer. 2014;14:687 pubmed publisher
  107. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  108. Herati R, Reuter M, Dolfi D, Mansfield K, Aung H, Badwan O, et al. Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults. J Immunol. 2014;193:3528-37 pubmed publisher
  109. Said A, Bock S, Müller G, Weindl G. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology. 2015;144:218-30 pubmed publisher
  110. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  111. Mena H, Lokajczyk A, Dizier B, Strier S, Voto L, Boisson Vidal C, et al. Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells. Angiogenesis. 2014;17:867-79 pubmed publisher
  112. Lozano Fernández T, Ballester Antxordoki L, Pérez Temprano N, Rojas E, Sanz D, Iglesias Gaspar M, et al. Potential impact of metal oxide nanoparticles on the immune system: The role of integrins, L-selectin and the chemokine receptor CXCR4. Nanomedicine. 2014;10:1301-10 pubmed publisher
  113. Wyler L, Napoli C, Ingold B, Sulser T, Heikenwalder M, Schraml P, et al. Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression. Br J Cancer. 2014;110:686-94 pubmed publisher
  114. Fuentes T, Appleby N, Tsay E, Martinez J, Bailey L, Hasaniya N, et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS ONE. 2013;8:e77464 pubmed publisher
  115. Sosińska Mielcarek K, Duchnowska R, Winczura P, Badzio A, Majewska H, Lakomy J, et al. Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: the role of Rad51. Breast. 2013;22:1178-83 pubmed publisher
  116. Barrero M, Sesé B, Marti M, Izpisua Belmonte J. Macro histone variants are critical for the differentiation of human pluripotent cells. J Biol Chem. 2013;288:16110-6 pubmed publisher
  117. Kim S, Moon G, Cho Y, Kang H, Hyung N, Kim D, et al. Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease. PLoS ONE. 2012;7:e37036 pubmed publisher
  118. Perdomo Arciniegas A, Vernot J. Co-culture of hematopoietic stem cells with mesenchymal stem cells increases VCAM-1-dependent migration of primitive hematopoietic stem cells. Int J Hematol. 2011;94:525-32 pubmed publisher
  119. Mortezavi A, Hermanns T, Seifert H, Baumgartner M, Provenzano M, Sulser T, et al. KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res. 2011;17:1111-21 pubmed publisher
  120. Liu Z, Tabakman S, Chen Z, Dai H. Preparation of carbon nanotube bioconjugates for biomedical applications. Nat Protoc. 2009;4:1372-82 pubmed publisher
  121. Welsch T, Keleg S, Bergmann F, Degrate L, Bauer S, Schmidt J. Comparative analysis of tumorbiology and CD133 positivity in primary and recurrent pancreatic ductal adenocarcinoma. Clin Exp Metastasis. 2009;26:701-11 pubmed publisher
  122. Ngai J, Inngjerdingen M, Berge T, Tasken K. Interplay between the heterotrimeric G-protein subunits Galphaq and Galphai2 sets the threshold for chemotaxis and TCR activation. BMC Immunol. 2009;10:27 pubmed publisher
  123. Koenen H, Smeets R, Vink P, van Rijssen E, Boots A, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood. 2008;112:2340-52 pubmed publisher
  124. Lai L, Vödrös D, Kozlowski P, Montefiori D, Wilson R, Akerstrom V, et al. GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine. Virology. 2007;369:153-67 pubmed
  125. Sato N, Fukushima N, Maitra A, Iacobuzio Donahue C, Van Heek N, Cameron J, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol. 2004;164:903-14 pubmed